Current News SFA Therapeutics Announces FDA Approval To Begin Clinical Trial To Treat Symptoms Of Psoriasis Posted on June 30, 2020March 2, 2021 by Khoa Ma 30 Jun SFA Therapeutics Announces FDA Approval To Begin Clinical Trial To Treat Symptoms Of Psoriasis Khoa Ma Jacob Becraft, CEO of Strand Therapeutics, Explains How We Can Build Better Pandemic Response Technologies And Become A "Post-Pandemic Species" Research Associate/Lab Manager Position Available at Synthis Therapeutics, (New York, NY)
